Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2008, Vol. 112, No. 6, pp. 2381-2389.
Prepublished online as a Blood First Edition Paper on June 23, 2008; DOI 10.1182/blood-2007-12-127779.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-12-127779v1
112/6/2381    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fourmentraux-Neves, E.
Right arrow Articles by Caignard, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fourmentraux-Neves, E.
Right arrow Articles by Caignard, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted December 7, 2007
Accepted May 29, 2008

Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells

Emmanuelle Fourmentraux-Neves, Abdelali Jalil, Sylvie Da Rocha, Christophe Pichon, Salem Chouaib, Georges Bismuth, and Anne Caignard*

U753, INSERM, Villejuif, France
U567, INSERM, Paris, France

* Corresponding author; email: caignard{at}cochin.inserm.fr.

Inhibitory killer Ig-like receptors (KIR), expressed by human Natural Killer cells and effector memory CD8+ T cell subsets, bind HLA-C molecules and suppress cell activation through recruitment of the Src homology 2 domain-containing protein tyrosine phosphatase 1 (SHP-1). To further analyse the still largely unclear role of inhibitory KIR receptors on CD4+ T cells, KIR2DL1 transfectants were obtained from a CD4+ T cell line and primary cells. Transfection of CD4+ T cells with KIR2DL1 dramatically increased the T cell receptor (TCR)-induced production of IL-2 independently of ligand binding, but inhibited TCR-induced activation after ligation. KIR-mediated costimulation of TCR activation involves intact KIR2DL1-ITIM phosphorylation, SHP-2 recruitment and PKC-{theta} phosphorylation. Synapses leading to activation were characterized by an increase in the recruitment of p-Tyr, SHP-2 and p-PKC{theta}, but not of SHP-1. Interaction of KIR2DL1 with its ligand led to a strong synaptic accumulation of KIR2DL1 and the recruitment of SHP-1/2, inhibiting TCR-induced IL-2 production. KIR2DL1 may induce two opposite signaling outputs in CD4+ T cells, depending on whether the KIR receptor is bound to its ligand. These data highlight unexpected aspects of the regulation of T cells by KIR2DL1 receptors, the therapeutic manipulation of which is currently being evaluated.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
G. Li, M. Yu, C. M. Weyand, and J. J. Goronzy
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells
Blood, October 15, 2009; 114(16): 3422 - 3430.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020